Latanoprost Demo

Latanoprost, the active ingredient in Latanoprost Demo, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It works by increasing uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure in adults diagnosed with primary open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost Demo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across global markets. The product meets EU pharmacopeial standards and is manufactured under strict Good Manufacturing Practice guidelines.

Latanoprost is indicated for conditions affecting aqueous humor dynamics within the open‑angle glaucoma disease family.

- Primary open‑angle glaucoma: reduces intra‑ocular pressure, helping to slow visual field loss. - Ocular hypertension: lowers pressure to prevent progression to glaucoma. - Open‑angle glaucoma (including pseudoexfoliative): improves pressure control when other agents are insufficient.

Latanoprost may cause ocular and peri‑ocular reactions, most of which are mild and transient.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual increase in brown pigment. - Eye irritation: foreign body sensation or mild itching.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract requiring medical attention. - Macular edema: swelling of the central retina that can affect vision.

Before prescribing Latanoprost, clinicians should consider several precautionary measures to ensure safe use.

- Pregnancy: Category C; use only if potential benefit justifies potential risk to the fetus. - Breastfeeding: Caution; limited data, weigh benefits against possible infant exposure. - Active ocular inflammation: Contraindicated; avoid use during uveitis or viral keratitis. - History of cystoid macular edema: Monitor closely; may exacerbate retinal swelling. - Concomitant ocular surgery: Delay use until wound healing is complete. - Store at room temperature: Keep the bottle tightly closed, protect from light and freezing.

Latanoprost can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Use with other prostaglandin analog eye drops: additive effect may increase risk of ocular side effects. - Combination with ocular hyperemia‑inducing agents (e.g., epinephrine): may worsen redness and discomfort.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intra‑ocular pressure reduction; monitor IOP. - Alpha‑agonist eye drops: potential enhanced pressure‑lowering effect; adjust therapy as needed. - Systemic carbonic anhydrase inhibitors: combined IOP‑lowering may be excessive; observe pressure. - Non‑steroidal anti‑inflammatory eye drops: may affect corneal healing; watch for irritation.